Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
990,150
-
Share change
-
+288,467
-
Total reported value
-
$1,053,747
-
Price per share
-
$1.07
-
Number of holders
-
34
-
Value change
-
+$300,647
-
Number of buys
-
11
-
Number of sells
-
13
Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q4 2023
As of 31 Dec 2023,
MiNK Therapeutics, Inc. - Stock (INKT) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
990,150 shares.
The largest 10 holders included
VANGUARD GROUP INC, Longbow Finance SA, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., CAPTRUST FINANCIAL ADVISORS, HighTower Advisors, LLC, CITADEL ADVISORS LLC, ORACLE INVESTMENT MANAGEMENT INC, and STATE STREET CORP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.